TRANSPLANTATION, KIDNEY

Clinical trials for TRANSPLANTATION, KIDNEY explained in plain language.

Never miss a new study

Get alerted when new TRANSPLANTATION, KIDNEY trials appear

Sign up with your email to follow new studies for TRANSPLANTATION, KIDNEY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New hope for transplant patients: experimental drug aims to replace standard Anti-Rejection medication

Disease control Not yet recruiting

This study is testing a new drug called VEL-101 to see if it can safely prevent the body from rejecting a new kidney after transplant. It will compare VEL-101 to the current standard medication, tacrolimus, in 120 people receiving a kidney transplant. Researchers want to see if V…

Matched conditions: TRANSPLANTATION, KIDNEY

Phase: PHASE2 • Sponsor: Veloxis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

TRANSPLANTATION, KIDNEY

Get alerted when new TRANSPLANTATION, KIDNEY trials appear

New hope for transplant patients: experimental drug aims to replace standard Anti-Rejection medication